AZD-5213 is a histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy. References: Jucaite A, Takano A, Bostrom E, Jostell KG, Stenkrona P, Halldin C, Segerdahl M, Nyberg S. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects. Int J Neuropsychopharmacol. 2013 Jul;16(6):1231-9. doi: 10.1017/S1461145712001411. Epub 2012 Dec 10. PubMed PMID: 23217964.

纯度：≥98%

CAS：1119807-02-1